October 16–18, 2026 | Montréal, Canada
The Global Strategy Lab team will join researchers, policymakers, practitioners and global health leaders at the 2026 Canadian Conference on Global Health (CCGH) in Montréal.
This year’s conference focuses on Collectively reclaiming global health equity, bringing together diverse perspectives to share knowledge, strengthen partnerships and advance more equitable global health solutions.
Our team will contribute to discussions on equity in antimicrobial resistance (AMR) policymaking, from improving antibiotic development and access to ensuring equity is central to decisions about which AMR interventions to prioritize.
Meet Our Team
Geneviève Boily-Larouche | Managing Director, AMR Policy Accelerator
A.M. (Adrian) Viens: Investigator, Global Strategy Lab; York Research Chair in Population Health Ethics and Law
Clare McGall: Policy Advisor, AMR Policy Accelerator
Lauren J. Wallace: Research Associate, AMR Policy Accelerator
Join Our Presentations
Lauren J. Wallace | October 16, 2:00 PM
Oral Session 10: Power, Financing and Accountability in Global Health Governance
(Re)Framing global discussions of antibiotic drug development and access through an equity lens: Findings from a scoping review
Lauren will share findings from a scoping review exploring how challenges and solutions related to antibiotic innovation are framed in research, and how equity can be better integrated into approaches to antibiotic development and access
Clare McGall | October 16, 2:00 PM
Oral Session 8: Governance, Financing and Political Economy of Health Systems
Embedding Equity in Antimicrobial Resistance Intervention Prioritization
Clare will explore how the Smart Choice Process (SCP), an evidence-informed approach to prioritizing AMR interventions, integrates equity into both the interventions selected and the decision-making process itself.
Attending CCGH? Connect with our team to exchange ideas and explore opportunities to advance equitable, evidence-informed AMR policymaking.
Previous